Quimioterapia de elección tras hormonoterapia en cáncer de mama metastásico - page 5

Advanced HR positive BC landscape: ongoing progress
Johnston S. SABCS 2016; Brufsky A Clin Med Insights 2015
Delaying CT in the treatment of HR+HER2- advanced BC
1,2,3,4 6,7,8,9,10,11,12,13,14,15,...36
Powered by FlippingBook